Status:
COMPLETED
Vascular Reactivity in Metabolic Syndrome and Diabetic Patients Using Diffuse Optical Spectroscopy
Lead Sponsor:
University of California, Irvine
Collaborating Sponsors:
Beckman Laser Institute University of California Irvine
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
45-75 years
Brief Summary
Metabolic Syndrome is a highly prevalent condition that is comprised of several major clustering factors that increase the risk for developing cardiovascular disease. Diffuse Optical Spectroscopy is a...
Detailed Description
The researchers can use Diffuse Optical Spectroscopy to monitor changes in the microvasculature of patients with Metabolic Syndrome and diabetic mellitus, and patients with Diabetic Peripheral and Aut...
Eligibility Criteria
Inclusion
- Adult ages of 45 to 75
- Have been clinically diagnosed with Type II Diabetes Mellitus
- Have a diagnosis of Metabolic Syndrome
Exclusion
- taking light-sensitive drugs for use in photodynamic therapy
- pregnant
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00793481
Start Date
November 1 2008
End Date
November 1 2013
Last Update
November 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beckman Laser Institute Medical clinic
Irvine, California, United States, 92612